News Releases

More than 10 percent of the facilities in the United States that perform transcatheter aortic valve replacement (TAVR) saw worse than expected outcomes in terms of survival and quality of life among patients who underwent the procedure, according to a new analysis led by researchers at the Perelman School of Medicine at the University of Pennsylvania.

The Center for Research on Coronaviruses and Other Emerging Pathogens aims to advance research efforts and support development of new therapies, vaccines.

Chimeric antigen receptor (CAR) T cell therapy has been a game-changer for blood cancers but has faced challenges in targeting solid tumors. Now researchers from the Perelman School of Medicine at the University of Pennsylvania may have an alternative to T cell therapy that can overcome those challenges.

Daniel Yoshor, MD, a nationally recognized neurosurgeon and neuroscientist, has been named chair of the department of Neurosurgery in the Perelman School of Medicine at the University of Pennsylvania and vice president of Clinical Integration and Innovation for the University of Pennsylvania Health System.

Early on in each cell, a critical protein known as FoxA2 simultaneously binds to both the chromosomal proteins and the DNA, opening the flood gates for gene activation, according to a new study led by researchers in the Perelman School of Medicine at the University of Pennsylvania.

The Perelman School of Medicine at the University of Pennsylvania (PSOM) has been ranked #3 among the nation’s medical schools, marking 23 consecutive years the school garnered honors among the top 10 research-oriented medical schools.

A team of researchers in the Perelman School of Medicine at the University of Pennsylvania (PSOM) are spearheading an industry-academic collaboration to better understand the development and progression of the disease and advance research efforts aimed at preserving kidney function in these patients.

An important biological mechanism that is thought to protect brain cells from neurodegenerative diseases such as Alzheimer’s and Parkinson’s may also be involved in regulating sleep, according to new research from the Perelman School of Medicine at the University of Pennsylvania.

In a first-of-its-kind study, researchers in the Perelman School of Medicine (PSOM) at the University of Pennsylvania showed that administering dantrolene through the nose increased its brain concentration and duration in a mouse model of Alzheimer’s disease without causing obvious adverse side effects.